Pregnancy and primary pulmonary hypertension: Successful outcome with epoprostenol therapy

Rosalyn Stewart, Divina Tuazon, Gayle Olson, Alexander G. Duarte

Research output: Contribution to journalArticle

81 Scopus citations

Abstract

Primary pulmonary hypertension (PPH) associated with pregnancy carries a high maternal mortality rate. Short-term epoprostenol infusion has been demonstrated to improve the hemodynamic profile in patients with PPH. We report a successful maternal-fetal outcome with epoprostenol therapy during pregnancy, cesarean section, and postpartum in a patient with PPH. Epoprostenol therapy did not produce any physical or developmental abnormalities in the fetus. A favorable maternal-fetal outcome may occur with a multidisciplinary approach.

Original languageEnglish (US)
Pages (from-to)973-975
Number of pages3
JournalChest
Volume119
Issue number3
DOIs
StatePublished - Jan 1 2001

Keywords

  • Cesarean section
  • Epoprostenol
  • Pregnancy
  • Pulmonary hypertension

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine
  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Pregnancy and primary pulmonary hypertension: Successful outcome with epoprostenol therapy'. Together they form a unique fingerprint.

  • Cite this